rs36117715

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_004369.4(COL6A3):​c.6653C>T​(p.Pro2218Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0383 in 1,613,906 control chromosomes in the GnomAD database, including 2,181 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. P2218P) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.072 ( 713 hom., cov: 32)
Exomes 𝑓: 0.035 ( 1468 hom. )

Consequence

COL6A3
NM_004369.4 missense

Scores

4
14

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: 0.355

Publications

19 publications found
Variant links:
Genes affected
COL6A3 (HGNC:2213): (collagen type VI alpha 3 chain) This gene encodes the alpha-3 chain, one of the three alpha chains of type VI collagen, a beaded filament collagen found in most connective tissues. The alpha-3 chain of type VI collagen is much larger than the alpha-1 and -2 chains. This difference in size is largely due to an increase in the number of subdomains, similar to von Willebrand Factor type A domains, that are found in the amino terminal globular domain of all the alpha chains. These domains have been shown to bind extracellular matrix proteins, an interaction that explains the importance of this collagen in organizing matrix components. Mutations in the type VI collagen genes are associated with Bethlem myopathy, a rare autosomal dominant proximal myopathy with early childhood onset. Mutations in this gene are also a cause of Ullrich congenital muscular dystrophy, also referred to as Ullrich scleroatonic muscular dystrophy, an autosomal recessive congenital myopathy that is more severe than Bethlem myopathy. Multiple transcript variants have been identified, but the full-length nature of only some of these variants has been described. [provided by RefSeq, Jun 2009]
COL6A3 Gene-Disease associations (from GenCC):
  • Bethlem myopathy 1A
    Inheritance: AD, AR, SD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Ambry Genetics
  • collagen 6-related myopathy
    Inheritance: AD, AR Classification: DEFINITIVE Submitted by: ClinGen
  • Ullrich congenital muscular dystrophy 1C
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • dystonia 27
    Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED, NO_KNOWN Submitted by: Illumina, Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics, Orphanet
  • Ullrich congenital muscular dystrophy 1A
    Inheritance: AR, AD, SD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Genomics England PanelApp
  • Bethlem myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Ullrich congenital muscular dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0039197206).
BP6
Variant 2-237353378-G-A is Benign according to our data. Variant chr2-237353378-G-A is described in ClinVar as Benign. ClinVar VariationId is 94967.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.172 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL6A3NM_004369.4 linkc.6653C>T p.Pro2218Leu missense_variant Exon 25 of 44 ENST00000295550.9 NP_004360.2 P12111-1D9ZGF2Q8N4Z1Q63HQ4
COL6A3NM_057167.4 linkc.6035C>T p.Pro2012Leu missense_variant Exon 24 of 43 NP_476508.2 P12111-2Q8N4Z1Q63HQ4
COL6A3NM_057166.5 linkc.4832C>T p.Pro1611Leu missense_variant Exon 22 of 41 NP_476507.3 P12111-4B7ZW00

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL6A3ENST00000295550.9 linkc.6653C>T p.Pro2218Leu missense_variant Exon 25 of 44 1 NM_004369.4 ENSP00000295550.4 P12111-1
COL6A3ENST00000472056.5 linkc.4832C>T p.Pro1611Leu missense_variant Exon 22 of 41 1 ENSP00000418285.1 P12111-4
COL6A3ENST00000353578.9 linkc.6035C>T p.Pro2012Leu missense_variant Exon 24 of 43 5 ENSP00000315873.4 P12111-2
COL6A3ENST00000491769.1 linkn.907C>T non_coding_transcript_exon_variant Exon 2 of 20 5

Frequencies

GnomAD3 genomes
AF:
0.0719
AC:
10936
AN:
152076
Hom.:
713
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.176
Gnomad AMI
AF:
0.0143
Gnomad AMR
AF:
0.0420
Gnomad ASJ
AF:
0.0936
Gnomad EAS
AF:
0.00519
Gnomad SAS
AF:
0.0315
Gnomad FIN
AF:
0.00904
Gnomad MID
AF:
0.0918
Gnomad NFE
AF:
0.0328
Gnomad OTH
AF:
0.0744
GnomAD2 exomes
AF:
0.0418
AC:
10515
AN:
251404
AF XY:
0.0396
show subpopulations
Gnomad AFR exome
AF:
0.186
Gnomad AMR exome
AF:
0.0297
Gnomad ASJ exome
AF:
0.0911
Gnomad EAS exome
AF:
0.00457
Gnomad FIN exome
AF:
0.00879
Gnomad NFE exome
AF:
0.0350
Gnomad OTH exome
AF:
0.0446
GnomAD4 exome
AF:
0.0348
AC:
50855
AN:
1461712
Hom.:
1468
Cov.:
32
AF XY:
0.0346
AC XY:
25136
AN XY:
727194
show subpopulations
African (AFR)
AF:
0.182
AC:
6078
AN:
33470
American (AMR)
AF:
0.0310
AC:
1388
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0898
AC:
2347
AN:
26132
East Asian (EAS)
AF:
0.00353
AC:
140
AN:
39700
South Asian (SAS)
AF:
0.0338
AC:
2915
AN:
86252
European-Finnish (FIN)
AF:
0.0110
AC:
588
AN:
53388
Middle Eastern (MID)
AF:
0.0860
AC:
496
AN:
5768
European-Non Finnish (NFE)
AF:
0.0307
AC:
34169
AN:
1111890
Other (OTH)
AF:
0.0453
AC:
2734
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.464
Heterozygous variant carriers
0
2471
4942
7414
9885
12356
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1350
2700
4050
5400
6750
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0719
AC:
10948
AN:
152194
Hom.:
713
Cov.:
32
AF XY:
0.0688
AC XY:
5123
AN XY:
74412
show subpopulations
African (AFR)
AF:
0.176
AC:
7286
AN:
41470
American (AMR)
AF:
0.0418
AC:
640
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.0936
AC:
325
AN:
3472
East Asian (EAS)
AF:
0.00501
AC:
26
AN:
5186
South Asian (SAS)
AF:
0.0314
AC:
151
AN:
4816
European-Finnish (FIN)
AF:
0.00904
AC:
96
AN:
10614
Middle Eastern (MID)
AF:
0.0884
AC:
26
AN:
294
European-Non Finnish (NFE)
AF:
0.0328
AC:
2230
AN:
68028
Other (OTH)
AF:
0.0736
AC:
155
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
486
972
1459
1945
2431
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
122
244
366
488
610
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0466
Hom.:
1031
Bravo
AF:
0.0801
TwinsUK
AF:
0.0297
AC:
110
ALSPAC
AF:
0.0304
AC:
117
ESP6500AA
AF:
0.173
AC:
761
ESP6500EA
AF:
0.0371
AC:
319
ExAC
AF:
0.0454
AC:
5508
Asia WGS
AF:
0.0230
AC:
80
AN:
3478
EpiCase
AF:
0.0371
EpiControl
AF:
0.0427

ClinVar

Significance: Benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:6
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 17, 2012
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 31, 2022
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 15, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 17, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:3
-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

-
Clinical Genetics, Academic Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Collagen 6-related myopathy Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Bethlem myopathy 1A Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.070
BayesDel_addAF
Benign
-0.45
T
BayesDel_noAF
Benign
-0.28
CADD
Benign
13
DANN
Benign
0.39
DEOGEN2
Benign
0.30
.;T;.;T;.
Eigen
Benign
-0.96
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.16
N
LIST_S2
Uncertain
0.86
D;D;D;D;.
MetaRNN
Benign
0.0039
T;T;T;T;T
MetaSVM
Benign
-0.76
T
MutationAssessor
Uncertain
2.3
.;M;.;.;.
PhyloP100
0.35
PrimateAI
Benign
0.30
T
PROVEAN
Uncertain
-3.5
D;D;D;.;D
REVEL
Benign
0.24
Sift
Benign
0.37
T;T;T;.;T
Sift4G
Uncertain
0.014
D;D;D;D;D
Polyphen
0.017
B;B;.;.;B
Vest4
0.13
MPC
0.15
ClinPred
0.010
T
GERP RS
-1.3
Varity_R
0.059
gMVP
0.21
Mutation Taster
=97/3
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
Splicevardb
2.0
SpliceAI score (max)
0.090
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs36117715; hg19: chr2-238262021; COSMIC: COSV55082067; COSMIC: COSV55082067; API